Stimulation evaluation test for people with sensitive skin of CBN serum - Stimulation evaluation test for people with sensitive skin of CBN serum

Kao Corporation0 sites60 target enrollmentApril 1, 2023

Overview

No summary available.

Registry

who.int

Start Date

April 1, 2023

End Date

July 31, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Sponsor

•1\. Person who are pregnant, breastfeeding, or may become pregnant in the near future. 2\. Person who have an underlying disease. 3\. Person who have skin symptoms that may interfere with the ability to accurately judge discomfort such as strong sunburn, wounds, and acne at the test site by visual observation of the test investigator. 4\. Person who are currently undergoing outpatient treatment for atopic dermatitis. 5\. Person who currently have allergic symptoms (hay fever, allergic rhinitis, etc.). 6\. Person who are currently undergoing facial skin treatment. 7\. Person who have participated in other exams. 8\. Person who have had fever or respiratory symptoms in themselves or a family member living with them during the two weeks before the start date of the measurement, or those who have been in close contact with a person infected with the new coronavirus. 9\. Person who plan or wish to be vaccinated against the new coronavirus infection from 2 weeks before the study participation to the end of the study. 10\. Person who are wearing pacemakers and implantable spinal cord stimulators. 11\. Person who are judged by the principal investigator or the person in charge of conducting the study to be inappropriate.